Disease | atrial fibrillation |
Phenotype | C0011860|type 2 diabetes |
Sentences | 12 |
PubMedID- 20659042 | [atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy]. |
PubMedID- PMC4125833 | The study is expected to give detailed information on the increased prevalence of atrial fibrillation in patients with type 2 diabetes and provides the data base for an optimized therapy regime in order to avoid cardio-vascular complications. |
PubMedID- 25266244 | Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. |
PubMedID- 23451184 | Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. |
PubMedID- 21985750 | Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the proactive study. |
PubMedID- 23672990 | Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. |
PubMedID- 26088442 | Risk factors for atrial fibrillation in type 2 diabetes: report from the swedish national diabetes register (ndr). |
PubMedID- 25192283 | Methods: in this prospective cohort study, 2,144 hong kong chinese with type 2 diabetes and without history of stroke or atrial fibrillation were recruited in 1994-1996 and followed up for a median of 14.51 years. |
PubMedID- 22981550 | type 2 diabetes mellitus and risk of incident atrial fibrillation in women. |
PubMedID- 22837366 | Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. |
PubMedID- 25713423 | High risk factors of atrial fibrillation in type 2 diabetes: results from the chinese kailuan study. |
PubMedID- 26476086 | Background: there are no proven strategies to prevent atrial fibrillation (af) in patients with type 2 diabetes (t2dm). |
Page: 1